Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B
- 31 December 1996
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (6) , 795-802
- https://doi.org/10.1016/s0168-8278(96)80281-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trialsJournal of Hepatology, 1994
- Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literatureJournal of Hepatology, 1993
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in ItalyHepatology, 1989
- Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.Gut, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Effect of 28 consecutive days lymphoblastoid interferon (α-IFN) administration on hepatitis B virus related chronic liver diseaseJournal of Hepatology, 1986
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984